Dual-Language B-MORE for Hypertension
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Behavioral: B-MORE (Brief Mindfulness-Oriented Recovery Enhancement).
- Who it may be relevant to
- Registry conditions: Hypertension (HTN), Chronic Stress. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
B-MORE for Hypertension
Overview
This pilot study is a single-arm clinical feasibility trial evaluating the feasibility, acceptability, and preliminary efficacy of a brief adaptation of Mindfulness-Oriented Recovery Enhancement (B-MORE) for reducing stress and high blood pressure in hypertensive English- and Spanish-speaking patients (n=20). The intervention, a 2-hour online training in stress management and hypertension, will be delivered virtually in a small-group format over two 60-minute sessions.
Interventions
- Behavioral Behavioral: B-MORE (Brief Mindfulness-Oriented Recovery Enhancement)
B-MORE is a validated, two-hour adaptation of the evidence-based MORE program. It retains each of the three, core therapeutic elements of the traditional MORE program (mindfulness, reappraisal, savoring) and is organized for delivery in two, 1-hour sessions.
Primary outcome measures
- Feasibility of the B-MORE intervention for Stress [Time frame: The expected time frame is from baseline to study completion, an average of 10 weeks.]
- Feasibility of the B-MORE intervention for Blood Pressure [Time frame: The expected time frame is from baseline to study completion, an average of 10 weeks.]
Secondary outcome measures (4)
- Treatment Acceptability for the B-MORE intervention for Stress [Time frame: Measured through participant self-report at the completion of the B-MORE program (immediately post-intervention and at 2-week and 6-week follow-up assessments).]
- Treatment Acceptability for the B-MORE intervention for Blood Pressure [Time frame: Measured through participant self-report at the completion of the B-MORE program (immediately post-intervention and at 2-week and 6-week follow-up assessments).]
- Treatment Expectancy for the B-MORE Intervention [Time frame: Measured through participant self-report at the completion of the B-MORE program (immediately post-intervention).]
- Treatment Satisfaction with the B-MORE Intervention [Time frame: Measured through participant self-report at the completion of the B-MORE program (immediately post-intervention and at the 2- and 6-week follow up points).]
Eligibility criteria
Inclusion criteria
- Age ≥18
- Having self-reported hypertension (BP ≥ 140/90)
- Understanding English or Spanish instructions fluently
Exclusion criteria
- Known or planned pregnancy in the next 3 months assessed via self-report
- Cognitive impairment preventing completion of study procedures.
- Have previous, formal mindfulness training (e.g., MBSR)
- Other unstable illness judged by medical staff to interfere with study involvement.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
United States · 1 center
- Shepherd's Hope Downtown Clinic — Orlando
Identifiers
NCT: NCT07623031 · STUDY00007273 Shepherd's Hope